Fritextsökning
Innehållstyper
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Ministermöte ska ge forskningsavtal
När Sverige gästas av Kinas forskningsminister signeras ett avtal om samarbete inom forskningen.
-
SDS rekryterar chef för RWE
Susanne Kihlblom blir ny affärsområdeschef för Real World Evidence, RWE, på SDS Life Science.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Immunicum byter vd
Carlos de Sousa tar över rodret på biotechbolaget efter Jamal El-Mosleh.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Nytt preparat utmanar ”fetmamedicinernas King Kong”
Slaget om marknaden för obesitasläkemedel fortsätter. Danska Novo Nordisk tar nu upp kampen mot medicinen som jämförts med en gastric bypass.
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
Lorviqua EU-godkänns som första linjens behandling mot avancerad lungcancer
Pfizers läkemedel Lorviqua har fått ett utvidgat godkännande i EU och ges nu grönt ljus som en första linjens behandling för ALK-positiv avancerad lungcancer.
-
Sales Representative, Applied Biosystems
-
Lovande resultat för atogepant som förebyggande behandling mot migrän
Behandling med läkemedelskandidaten atogepant gav en signifikant minskning av antalet dagar med migrän eller huvudvärk hos patienter i en fas III-studie.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
New type of stem cell discovered
The earlier view of the scientific community was that melanocytes, the pigment cells, derive from the spinal cord during the early fetal period and then move ov...
-
Han blir vd för Stockholm Business Region
Staffan Ingvarsson, tidigare vd på Stokab, tillträder den 1 april som vd för Stockholm Business Region.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.